Curanex Pharmaceuticals Inc Research and Development Expense
Curanex Pharmaceuticals Inc (CURX) reported Research and Development Expense of $2.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Curanex Pharmaceuticals Inc research and development expense for the quarter ending 2026-06-30 was $2.59M.
- Curanex Pharmaceuticals Inc research and development expense for the quarter ending 2026-03-31 was $2.26M.
- Curanex Pharmaceuticals Inc research and development expense for the quarter ending 2025-12-31 was $2.31M.
- Curanex Pharmaceuticals Inc research and development expense for the quarter ending 2025-09-30 was $677.47K.
- Curanex Pharmaceuticals Inc research and development expense for fiscal 2025 was $2.99M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.59M 10-Q · filed 2026-08-14 | $4.85M 10-Q · filed 2026-08-14 | $7.16M derived: sum of 3 quarters · filed 2026-08-14 | $7.83M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.26M 10-Q · filed 2026-05-14 | $4.56M derived: sum of 2 quarters · filed 2026-05-14 | $5.24M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.98M derived: sum of 2 quarters · filed 2026-03-30 | $2.99M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $677.47K 10-Q · filed 2025-11-17 | $679.57K 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |